Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Integrin beta 1D Antibody (1G2), Janelia Fluor™ 549, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP197733JF549
Description
Integrin beta 1D Monoclonal specifically detects Integrin beta 1D in Human, Mouse samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen.Specifications
Integrinbeta1D | |
Monoclonal | |
Janelia Fluor 549 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
ITGB1 | |
Clone 1G2 is a mouse monoclonal IgG2a, kappa antibody derived by fusion of SP2/0 mouse myeloma cells with spleen cells from a mouse immunized with a synthetic peptide corresponding to the Cterminal 24 amino acids of integrin beta1D including an appending N-terminal cysteine (CQENPIYKSPINNFKNPNYGRKAGL) coupled to keyhole limpet hemocyanin. | |
0.1 mL | |
Primary | |
1G2 recognizes specifically the cytoplasmic domain of integrin subunit beta 1D present in cardiac and skeletal muscle. | |
Store at 4°C in the dark. | |
IgG2a |
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Frozen) | |
1G2 | |
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen | |
integrin beta-1, CD29, FNRB, GPIIA, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), MDF2, MSK12, VLAB, VLA-BETA | |
Mouse | |
Protein A or G purified | |
Cancer, Cytokine Research, Cytoskeleton Markers, Embryonic Stem Cell Markers, Immunology, Mesenchymal Stem Cell Markers, Neuronal Cell Markers, Neuronal Stem Cell Markers, Signal Transduction, Stem Cell Markers | |
3688 | |
Human, Mouse, Pig | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction